Latest News

Revance is a biotechnology company focused on innovative aesthetic and therapeutic offerings, as well as financial technology services for aesthetic practices.

Dermatology Times logo

FDA Accepts BLA Resubmission for DAXI Injections

Street Insider Logo

Revance Therapeutics (RVNC) Announces FDA Acceptance of BLA Resubmission for DaxibotulinumtoxinA for Injection for Glabellar Lines)

Bezinga Logo

Revance Receives FDA Acceptance of BLA Resubmission for DaxiboutlinumtoxinA for Glabellar Lines

Seeking Alpha logo

FDA Accepts Revance Application for Its Injection To Treat Frown Lines